BACKGROUND: The objective of this study was to explore relations between patient role preferences during the cancer treatment decision-making process and quality of life (QOL). METHODS: One-year cancer survivors completed a survey in 2000 as part of a larger survey conducted by the American Cancer Society. The current report was based on survey respondents from Minnesota (response rate, 37.4%). Standardized measures included the Profile of Mood States (scores were converted to have a range, from 0 to 100, with 100 indicating the best mood), the Medical Outcomes Survey 36-item short-form health survey (SF-36) (standardized scores), and the Control Preferences Scale. Patients' actual and preferred role preference distributions and concordance between roles were compared with QOL scores using 2-sample t test methodology. RESULTS: The actual role of survivors (n = 594) in cancer care was 33% active, 50% collaborative, and 17% passive. Their preferred role was 35% active, 53% collaborative, and 13% passive. Overall, 88% of survivors had concordant preferred and actual roles. Survivors who had concordant roles had higher SF-36 Physical Component Scale (PCS) scores (P < .01), higher vitality (P = .01), less fatigue (P < .01), less confusion (P = .01), less anger (P = .046), and better overall mood (P = .01). These results were similar among both women and younger individuals (aged <60 years). Survivors who had active actual roles had higher PCS scores (P < .01), less tension (P = .04), and higher vitality (P = .04) than survivors who were either collaborative or passive. No differences existed in QOL scores according to preferred role. CONCLUSIONS: Survivors who experienced discordance between their actual role and their preferred role reported substantial QOL deficits in both physical and emotional domains. These results indicate the need to support patient preferences.
BACKGROUND: The objective of this study was to explore relations between patient role preferences during the cancer treatment decision-making process and quality of life (QOL). METHODS: One-year cancer survivors completed a survey in 2000 as part of a larger survey conducted by the American Cancer Society. The current report was based on survey respondents from Minnesota (response rate, 37.4%). Standardized measures included the Profile of Mood States (scores were converted to have a range, from 0 to 100, with 100 indicating the best mood), the Medical Outcomes Survey 36-item short-form health survey (SF-36) (standardized scores), and the Control Preferences Scale. Patients' actual and preferred role preference distributions and concordance between roles were compared with QOL scores using 2-sample t test methodology. RESULTS: The actual role of survivors (n = 594) in cancer care was 33% active, 50% collaborative, and 17% passive. Their preferred role was 35% active, 53% collaborative, and 13% passive. Overall, 88% of survivors had concordant preferred and actual roles. Survivors who had concordant roles had higher SF-36 Physical Component Scale (PCS) scores (P < .01), higher vitality (P = .01), less fatigue (P < .01), less confusion (P = .01), less anger (P = .046), and better overall mood (P = .01). These results were similar among both women and younger individuals (aged <60 years). Survivors who had active actual roles had higher PCS scores (P < .01), less tension (P = .04), and higher vitality (P = .04) than survivors who were either collaborative or passive. No differences existed in QOL scores according to preferred role. CONCLUSIONS: Survivors who experienced discordance between their actual role and their preferred role reported substantial QOL deficits in both physical and emotional domains. These results indicate the need to support patient preferences.
Authors: Jasvinder A Singh; Jeff A Sloan; Pamela J Atherton; Tenbroeck Smith; Thomas F Hack; Mashele M Huschka; Teresa A Rummans; Matthew M Clark; Brent Diekmann; Lesley F Degner Journal: Am J Manag Care Date: 2010-09 Impact factor: 2.229
Authors: Jennifer J Griggs; Melony E S Sorbero; Julie B Mallinger; Megan Quinn; Margaret Waterman; Beverly Brooks; Brian Yirinec; Cleveland G Shields Journal: Patient Educ Couns Date: 2006-11-29
Authors: Nelleke M Korteland; Derya Top; Gerard J J M Borsboom; Jolien W Roos-Hesselink; Ad J J C Bogers; Johanna J M Takkenberg Journal: Interact Cardiovasc Thorac Surg Date: 2016-02-25
Authors: Alexis Colley; Jodi Halpern; Steven Paul; Guy Micco; Maureen Lahiff; Fay Wright; Jon D Levine; Judy Mastick; Marilyn J Hammer; Christine Miaskowski; Laura B Dunn Journal: Psychooncology Date: 2016-10-05 Impact factor: 3.894
Authors: Donald R Sullivan; Sara E Golden; Linda Ganzini; Renda Soylemez Wiener; Karen B Eden; Christopher G Slatore Journal: Ann Am Thorac Soc Date: 2017-11